Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)
Titel:
Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)
Auteur:
Sun, Roger Champiat, Stéphane Dercle, Laurent Aspeslagh, Sandrine Castanon, Eduardo Limkin, Elaine Johanna Baldini, Capucine Postel-Vinay, Sophie Hollebecque, Antoine Massard, Christophe Ammari, Samy Deutsch, Eric Soria, Jean-Charles Marabelle, Aurélien Ferté, Charles